The FDA rejected a drug that is meant to boost a womans libido. Sprout Pharmaceuticals says its at an impasse with the agency over the companys pink







Libido-boosting 'female Viagra' in Limbo [7OniUvppz4H]

Libido-boosting 'female Viagra' in Limbo [7OniUvppz4H]

| 1h 28m 28s | Video has closed captioning.

The FDA rejected a drug that is meant to boost a woman's libido. Sprout Pharmaceuticals says it's at an impasse with the agency over the company's pink pill, Flibanserin, leaving the 15-year search for a 'female Viagra' in limbo. (Dec. 11) The Associated Press is the essential global news network, delivering fast, unbiased news from every corner of the world to all media platforms and formats. AP's commitment to independent, comprehensive journalism has deep roots. Founded in 1846, AP has covered all the major news events of the past 165 years, providing high-quality, informed reporting of everything from wars and elections to championship games and royal weddings. AP is the largest and most trusted source of independent news and information. Today, AP employs the latest technology to collect and distribute content - we have daily uploads covering the latest and breaking news in the world of politics, sport and entertainment. Join us in a conversation about world events, the newsgathering process or whatever aspect of the news universe you find interesting or important. Subscribe:

Aired: November 24, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now